Medications for Hormone Receptor Positive Breast Cancer

3 results

  • afinitor - everolimus tablet

    (Everolimus)
    Novartis Pharmaceuticals Corporation
    Afinitor treats advanced HR+/HER2- breast cancer (with exemestane), progressive neuroendocrine tumors (pancreatic, GI, or lung), advanced renal cell carcinoma, and tuberous sclerosis complex (TSC)-associated renal angiomyolipoma, SEGA, and partial-onset seizures in adults and pediatric patients.
    Medication Details
    Drug Interactions

  • faslodex - fulvestrant injection

    (Fulvestrant)
    Astrazeneca Pharmaceuticals Lp
    FASLODEX treats HR-positive, HER2-negative advanced or metastatic breast cancer in postmenopausal women. Used as monotherapy (treatment-naive or after endocrine therapy) or combined with ribociclib, palbociclib, or abemaciclib following disease progression on endocrine therapy.
    Medication Details
    Drug Interactions

  • trodelvy - sacituzumab govitecan powder, for solution

    (Sacituzumab Govitecan)
    Gilead Sciences, Inc.
    Trodelvy treats adults with unresectable locally advanced or metastatic triple-negative breast cancer (2+ prior systemic therapies) or HR-positive, HER2-negative breast cancer (endocrine therapy plus 2+ additional metastatic systemic therapies).
    Medication Details
    Drug Interactions